147 related articles for article (PubMed ID: 1541312)
1. Twenty-four hour blood pressure profiles in hypertensive patients following various formulations and dosage regimens of felodipine.
Blychert E; Frisén M; Karlsson O; Rydén L
Eur J Clin Pharmacol; 1992; 42(1):25-30. PubMed ID: 1541312
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.
Blychert E; Wingstrand K; Edgar B; Lidman K
Br J Clin Pharmacol; 1990 Jan; 29(1):39-45. PubMed ID: 2404502
[TBL] [Abstract][Full Text] [Related]
3. Felodipine extended-release tablets once daily are equivalent to plain tablets twice daily in treating hypertension. Dutch Hospital Multicentre Group.
Hart W; Westberg B
J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S65-9. PubMed ID: 1693733
[TBL] [Abstract][Full Text] [Related]
4. Comparison of felodipine extended release and conventional tablets in essential hypertension using ambulatory blood pressure monitoring.
McGrath BP; Langton D; Matthews PG; Syme S; Treloar K; McNeil JJ
J Hypertens; 1989 Aug; 7(8):645-51. PubMed ID: 2681410
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study.
Bonaduce D; Canonico V; Petretta M; Forgione L; Ianniciello A; Cavallaro V; Bertocchi F; Rengo F
Eur J Clin Pharmacol; 1997; 53(2):95-100. PubMed ID: 9403278
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.
Hedner T; Elmfeldt D; Dahlöf C; Sjögren E
Drugs; 1987; 34 Suppl 3():125-31. PubMed ID: 3443058
[TBL] [Abstract][Full Text] [Related]
7. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
Antonicelli R; Omboni S; Giovanni DC; Ansuini R; Mori A; Gesuita R; Parati G; Paciaroni E
Drugs Aging; 2002; 19(7):541-51. PubMed ID: 12182690
[TBL] [Abstract][Full Text] [Related]
8. Cross-over comparison of nifedipine Oros and felodipine extended release with blind 24 h ambulatory blood pressure assessments.
Taverner D; Marley J; Tonkin AL
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):909-13. PubMed ID: 10561813
[TBL] [Abstract][Full Text] [Related]
9. Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard.
Littler WA
Br J Clin Pharmacol; 1990 Dec; 30(6):871-8. PubMed ID: 2288833
[TBL] [Abstract][Full Text] [Related]
10. The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients.
McLay JS; MacDonald TM; Hosie J; Elliott HL;
Eur J Clin Pharmacol; 2000 Nov; 56(8):529-35. PubMed ID: 11151741
[TBL] [Abstract][Full Text] [Related]
11. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
12. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
Leenen FH; Coletta E; White R
J Hypertens; 2006 Jan; 24(1):177-84. PubMed ID: 16331116
[TBL] [Abstract][Full Text] [Related]
13. Clinical equivalence of two tablet formulations of felodipine. A placebo-controlled study of 24-hour blood pressure control and tolerability.
McGrath BP; Watts RW; Elmfeldt DB
Eur J Clin Pharmacol; 1995; 49(3):169-72. PubMed ID: 8665991
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour antihypertensive efficacy of felodipine 10 mg extended-release: the Italian inter-university study.
Pannarale G; Puddu PE; Monti F; Irace L; Bentivoglio M; Collauto F; Barsotti A; Corea L; Trevi G; Campa PP; Jacono A
J Cardiovasc Pharmacol; 1996 Feb; 27(2):255-61. PubMed ID: 8720425
[TBL] [Abstract][Full Text] [Related]
15. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording.
Fariello R; Boni E; Corda L; Cantalamessa A; Zaninelli A; Pollavini G; Alicandri C; Muiesan G
Am J Hypertens; 1991 Jan; 4(1 Pt 1):27-33. PubMed ID: 2006994
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect and tolerability of felodipine extended release (ER) tablets in comparison with felodipine plain tablets (PT) and placebo in hypertensives on a diuretic. Canadian Study Group.
Carruthers SG; Vint-Reed C
Clin Invest Med; 1993 Oct; 16(5):386-94. PubMed ID: 8261692
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.
Koenig W; Sund M; Binner L; Hehr R; Rosenthal J; Hombach V
Eur J Clin Pharmacol; 1991; 41(3):197-9. PubMed ID: 1748135
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
Hoffmann J
Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
